Clinical trial
The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
NCT00531843 is registered in ClinicalTrials.gov with Mary Knudson, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients
- Lead sponsor
- Mary Knudson, M.D.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 31, 2007
- Completion date
- June 30, 2008
- Enrollment
- 105 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.